Market Trends– category –
-
Japan Leads Global Stem Cell Research, Excels in Treatment Costs, Methods, and Safety
PlacidWay Japan Overview A PlacidWay infographic report highlights Japan as a global leader in regenerative medicine research, emphasizing its highly structured regulatory environment for stem cell therapy. Japan is particularly well-sui... -
Japan’s Stem Cell Therapy Landscape: High Costs and Strict MHLW Regulations Govern Regenerative Medicine Hubs
PlacidWay Japan Overview Leading stem cell therapy clinics in Japan, such as Cell Grand Clinic and Clinique Haru Osaka Umeda, offer regenerative medicine for conditions like joint disorders, musculoskeletal diseases, diabetes, and Parkin... -
Modular Bioprocessing Future: Digital Twins and AI Revolutionize Manufacturing, Drastically Reducing Downtime
Industry Publication Unknown Overview Modular bioprocessing is evolving with digital control and AI, significantly boosting efficiency and reliability in biopharmaceutical manufacturing. Digital twin technology is key, enabling predictiv... -
The Bioreactor Scaling Conundrum: Navigating Flexibility, Yield, and Design Trade-offs in Biopharmaceutical Manufacturing
Nature Partnerships International Overview Scaling bioprocess production in bioreactors presents a formidable challenge, characterized by inherent trade-offs between flexibility, cell yield, and process design. Bioreactor specifications ... -
Northway Biotech Opens €61M Cell Therapy and Personalized Medicine CDMO in Vilnius, Marking Baltic Region’s First
PR Newswire Lithuania Overview Northway Biotech has launched a pioneering €61 million ($65M USD) cell therapy and personalized medicine CDMO facility in Vilnius, Lithuania, establishing the first such hub in the Baltics. This 3,500-squar... -
Technology Networks Delineates Commercialization Strategies for iPSC Therapies: Automated Manufacturing and Immune-Evasive Cell Line Development are Key
Technology Networks UK Overview Technology Networks provides an in-depth analysis of strategic challenges and solutions for the commercial viability of iPSC-based therapies, emphasizing the critical importance of scalable manufacturing, ... -
Small-Scale Bioreactors Market Sees Robust Growth Driven by Innovation; Culture Biosciences and Cytiva Bioscience Partnership Advances Automation
openPR.com International Overview This article provides an overview of a market research report introduced by openPR.com, highlighting significant growth in the small-scale bioreactors market, driven by innovations in bioprocessing effic... -
Ballard Power Systems Acquires UK-Based GeoPura for ~$400 Million, Pivoting to Integrated Hydrogen Power Solutions and Energy-as-a-Service
Energy News UK Overview Ballard Power Systems has finalized its acquisition of UK-based GeoPura for approximately $400 million (enterprise value), including £275 million in upfront cash and shares. This strategic move transforms Ballard ... -
Green Hydrogen Investments Projected to Hit $10 Billion in 2026, Yet 100+ GW Projects Face Critical 2027 FID Deadline
GreentechLead USA Overview Global green hydrogen investments are forecast to reach $10 billion in 2026, boosting committed annual production capacity to 4.3 million tonnes. However, over 100 GW of electrolysis projects must secure final ... -
OMV Petrom Transforms Petrobrazi Refinery into Low-Carbon Hydrogen Hub, Pioneering Eastern European Decarbonization
Hydrogen Fuel News Romania Overview OMV Petrom, Romania's leading energy company, is strategically transforming its Petrobrazi refinery into a regional low-carbon hydrogen production hub. This initiative aims to decarbonize the refinery'...
